EXPERT ALTERNATIVES LAUNCHES FIRST SUPPLEMENT FIBROVA, DESIGNED BY DOCTORS TO HELP WOMEN REDUCE AND PREVENT FIBROID TUMORS

EXPERT ALTERNATIVES LAUNCHES FIRST SUPPLEMENT FIBROVA, DESIGNED BY DOCTORS TO HELP WOMEN REDUCE AND PREVENT FIBROID TUMORS

Expert Alternatives, a new company built on the mission of offering women research-backed, natural supplements designed by leading physicians to combat common conditions, today announced the launch of its first product Fibrova. Fibrova is specifically formulated to support the management of fibroids, the most frequently seen tumors in the female reproductive system.

“More than 50% of women experience Fibroids at some point in time,” said Charles J Ascher-Walsh, MD the Director of the Division of Gynecology, Director of the Division of Urogynecology and Co-director of the Division of Minimally Invasive Surgery at The Mount Sinai Hospital in New York City who founded Expert Alternatives. “These tumors can be painful, cause heavy bleeding and negatively effect fertility. They very often lead to surgery. Our mission is to help women prevent those negative outcomes.”

Fibrova is formulated with a proprietary blend of vitamins D & K, Green Tea Extract (Epigallocatechin Gallate, or EGCG) and Chastetree Berry Extract to encourage the shrinking of existing fibroid tumors and suppress growth while reducing the severity of symptoms. According to a study from researchers at the National Institutes of Health, women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D. In other clinical trials, green tea extract (epigallocatechin gallate, or EGCG) reduced the severity of fibroid symptoms. Women who took green tea extract experienced fewer severe symptoms, and fibroid size shrank by an average of 32.6 percent.

Fibroids, also known as uterine leiomyomata, are noncancerous tumors of the uterus, which most commonly occur in women between the ages 30 and 50. They frequently result in pain and bleeding in premenopausal women, and are the leading cause of hysterectomy in the United States. In more than 99 percent of fibroid cases, the tumors are benign (non-cancerous) however the symptoms can be severe. They can cause infertility or pregnancy loss and raise the risk of certain pregnancy complications, such as placental abruption, fetal growth restriction and preterm delivery.

Fibrova is available to consumers at www.ExpertAlternatives.com beginning today. A 30-day supply will cost $14.99 and consumers can also subscribe to receive the product monthly for $13.33 per one-month supply.

This Post Has 2 Comments

  1. Hi Doctor. I tried to buy but. I can’t I. Was today. In you office.

    1. Please let us know what problems you are having with the website. As far as we can tell it is working appropriately. Thank you for your interest in Fibrova

Leave a Reply

Close Menu